Skip to NavigationSkip to content

News

Boehringer Ingelheim and Eli Lilly have announced strong Phase 3 news on their sodium-glucose co-transporter-2 (SGLT2) inhibitor Jardiance (...
Sanofi’s nirsevimab met its goals in a Phase 2b study, the company has revealed, investigating its efficacy in the prevention of respiratory...
UCB Pharma is set to partner up with Roche and Genentech in a development and commercialisation deal focused on its drug candidate UCB0107, designed...
While the company has more recently drawn headlines for its COVID-19 efforts, BioNTech has unveiled promising interim Phase 1 data for its mRNA-based...
NICE has issued draft guidance that has shot down Kyowa Kirin’s therapy Poteligeo (mogamulizumab) for use on the NHS in England and Wales for the...
Japan’s biggest drug firm Takeda is said to be mulling plans to cut back its sales operations with a new restructuring programme as part of its...
Hydroxychloroquine continues its downwards spiral as Moderna's COVID vaccine secures a futher $472 million investment from the US Government. Read...
The European Commission has awarded its approval for Novartis’ Piqray (alpelisib) to be made available in combination with fulvestrant in the...
The UK Government has sealed another deal to procure an effective COVID-19 vaccine for its citizens, partnering up with Sanofi and GlaxoSmithKline to...
Roche has announced the disappointing news that its therapy Actemra/RoActemra (tocilizumab) failed to improve clinical status to a statistically...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches